Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mujun Liu

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
ACS Chemical Neuroscience|July 29, 2022
Stress Granule Homeostasis, Aberrant Phase Transition, and Amyotrophic Lateral SclerosisZhanxu Li, Xionghao Liu, Mujun Liu
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|November 22, 2022
Application of mesenchymal stem cells in tumor therapyXiangling Tang, Yu Zhang, Xionghao Liu, et al.
Journal of Cellular Physiology|December 4, 2020
Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targetsBenhui Liang, Ximin Hu, Yinghe Ding, et al.
Human Gene Therapy|January 26, 2018
Gene Therapy for Hemophilia and Duchenne Muscular Dystrophy in ChinaXionghao Liu, Mujun Liu, Lingqian Wu, et al.
Reviews in the Neurosciences|July 19, 2020
The role of exosome lipids in central nervous system diseasesGe Wang, Yong Wang, Ningyuan Liu, et al.
Frontiers in Physiology|December 19, 2022
A deep feature fusion network for fetal state assessmentYahui Xiao, Yaosheng Lu, Mujun Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 29, 2024
Development and external validation of a multi-task feature fusion network for CTV segmentation in cervical cancer radiotherapyZhe Wu, Liming Lu, Cheng Xu, et al.
Technology in Cancer Research & Treatment|April 8, 2024
A Comparative Study of Deep Learning Dose Prediction Models for Cervical Cancer Volumetric Modulated Arc TherapyZhe Wu, Mujun Liu, Ya Pang, et al.
Journal of Neurochemistry|November 13, 2013
Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradationYuxing Xia, Linda H Yan, Bo Huang, et al.
Frontiers in Pharmacology|October 28, 2022
The status of industrialization and development of exosomes as a drug delivery system: A reviewYi Yin, Xing Han, Cheng Li, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
ACS Chemical Neuroscience|July 29, 2022
Stress Granule Homeostasis, Aberrant Phase Transition, and Amyotrophic Lateral SclerosisZhanxu Li, Xionghao Liu, Mujun Liu
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|November 22, 2022
Application of mesenchymal stem cells in tumor therapyXiangling Tang, Yu Zhang, Xionghao Liu, et al.
Journal of Cellular Physiology|December 4, 2020
Tumor-derived exosomes in the PD-1/PD-L1 axis: Significant regulators as well as promising clinical targetsBenhui Liang, Ximin Hu, Yinghe Ding, et al.
Human Gene Therapy|January 26, 2018
Gene Therapy for Hemophilia and Duchenne Muscular Dystrophy in ChinaXionghao Liu, Mujun Liu, Lingqian Wu, et al.
Reviews in the Neurosciences|July 19, 2020
The role of exosome lipids in central nervous system diseasesGe Wang, Yong Wang, Ningyuan Liu, et al.
Frontiers in Physiology|December 19, 2022
A deep feature fusion network for fetal state assessmentYahui Xiao, Yaosheng Lu, Mujun Liu, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 29, 2024
Development and external validation of a multi-task feature fusion network for CTV segmentation in cervical cancer radiotherapyZhe Wu, Liming Lu, Cheng Xu, et al.
Technology in Cancer Research & Treatment|April 8, 2024
A Comparative Study of Deep Learning Dose Prediction Models for Cervical Cancer Volumetric Modulated Arc TherapyZhe Wu, Mujun Liu, Ya Pang, et al.
Journal of Neurochemistry|November 13, 2013
Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradationYuxing Xia, Linda H Yan, Bo Huang, et al.
Frontiers in Pharmacology|October 28, 2022
The status of industrialization and development of exosomes as a drug delivery system: A reviewYi Yin, Xing Han, Cheng Li, et al.
Pageof 3